<?xml version="1.0" encoding="UTF-8"?>
<ref id="rmv2143-bib-0042">
 <label>42</label>
 <mixed-citation publication-type="miscellaneous" id="rmv2143-cit-0042">
  <string-name>
   <surname>Chen</surname>
   <given-names>C</given-names>
  </string-name>, 
  <string-name>
   <surname>Huang</surname>
   <given-names>J</given-names>
  </string-name>, 
  <string-name>
   <surname>Cheng</surname>
   <given-names>Z</given-names>
  </string-name>, et al. Favipiravir versus arbidol for COVID‚Äê19: a randomized clinical trial. medRxiv. 2020. 
  <ext-link ext-link-type="uri" xlink:href="https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v2" xmlns:xlink="http://www.w3.org/1999/xlink">https://www.medrxiv.org/content/10.1101/2020.03.17.20037432v2</ext-link>. Accessed April 4, 2020.
 </mixed-citation>
</ref>
